Medical Devices & Consumables
Global Insulin Consumables Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 606257
- Pages: 143
- Figures: 140
- Views: 1
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Insulin Consumables market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medtronic
SOOIL
Insulet
Tandem
LenoMed Medical
Maishitong
Phray
Apex Medical
Fornia
MicroTech Medical (Hangzhou) Co., Ltd
Segment by Type
Patch Pump
Conventional Pump
Segment by Application
Type I Diabetes
Type II Diabetes
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Insulin Consumables study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Insulin Consumables market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medtronic
SOOIL
Insulet
Tandem
LenoMed Medical
Maishitong
Phray
Apex Medical
Fornia
MicroTech Medical (Hangzhou) Co., Ltd
Segment by Type
Patch Pump
Conventional Pump
Segment by Application
Type I Diabetes
Type II Diabetes
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Insulin Consumables study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Insulin Consumables: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Insulin Consumables Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Patch Pump
1.2.3 Conventional Pump
1.3 Market Segmentation by Application
1.3.1 Global Insulin Consumables Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Insulin Consumables Revenue Estimates and Forecasts 2020-2031
2.2 Global Insulin Consumables Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Insulin Consumables Sales Estimates and Forecasts 2020-2031
2.4 Global Insulin Consumables Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Insulin Consumables Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Insulin Consumables Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Patch Pump Market Size by Manufacturers
3.5.2 Conventional Pump Market Size by Manufacturers
3.6 Global Insulin Consumables Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Insulin Consumables Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Insulin Consumables Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Insulin Consumables Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Insulin Consumables Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Insulin Consumables Sales and Revenue by Type (2020-2031)
6.4 North America Insulin Consumables Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Insulin Consumables Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Insulin Consumables Sales and Revenue by Type (2020-2031)
7.4 Europe Insulin Consumables Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Insulin Consumables Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Insulin Consumables Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Insulin Consumables Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Insulin Consumables Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Insulin Consumables Sales and Revenue by Type (2020-2031)
9.4 Central and South America Insulin Consumables Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Insulin Consumables Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Insulin Consumables Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Insulin Consumables Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Insulin Consumables Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Insulin Consumables Product Models, Descriptions and Specifications
11.1.4 Medtronic Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Insulin Consumables Sales by Product in 2024
11.1.6 Medtronic Insulin Consumables Sales by Application in 2024
11.1.7 Medtronic Insulin Consumables Sales by Geographic Area in 2024
11.1.8 Medtronic Insulin Consumables SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 SOOIL
11.2.1 SOOIL Corporation Information
11.2.2 SOOIL Business Overview
11.2.3 SOOIL Insulin Consumables Product Models, Descriptions and Specifications
11.2.4 SOOIL Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 SOOIL Insulin Consumables Sales by Product in 2024
11.2.6 SOOIL Insulin Consumables Sales by Application in 2024
11.2.7 SOOIL Insulin Consumables Sales by Geographic Area in 2024
11.2.8 SOOIL Insulin Consumables SWOT Analysis
11.2.9 SOOIL Recent Developments
11.3 Insulet
11.3.1 Insulet Corporation Information
11.3.2 Insulet Business Overview
11.3.3 Insulet Insulin Consumables Product Models, Descriptions and Specifications
11.3.4 Insulet Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Insulet Insulin Consumables Sales by Product in 2024
11.3.6 Insulet Insulin Consumables Sales by Application in 2024
11.3.7 Insulet Insulin Consumables Sales by Geographic Area in 2024
11.3.8 Insulet Insulin Consumables SWOT Analysis
11.3.9 Insulet Recent Developments
11.4 Tandem
11.4.1 Tandem Corporation Information
11.4.2 Tandem Business Overview
11.4.3 Tandem Insulin Consumables Product Models, Descriptions and Specifications
11.4.4 Tandem Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Tandem Insulin Consumables Sales by Product in 2024
11.4.6 Tandem Insulin Consumables Sales by Application in 2024
11.4.7 Tandem Insulin Consumables Sales by Geographic Area in 2024
11.4.8 Tandem Insulin Consumables SWOT Analysis
11.4.9 Tandem Recent Developments
11.5 LenoMed Medical
11.5.1 LenoMed Medical Corporation Information
11.5.2 LenoMed Medical Business Overview
11.5.3 LenoMed Medical Insulin Consumables Product Models, Descriptions and Specifications
11.5.4 LenoMed Medical Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 LenoMed Medical Insulin Consumables Sales by Product in 2024
11.5.6 LenoMed Medical Insulin Consumables Sales by Application in 2024
11.5.7 LenoMed Medical Insulin Consumables Sales by Geographic Area in 2024
11.5.8 LenoMed Medical Insulin Consumables SWOT Analysis
11.5.9 LenoMed Medical Recent Developments
11.6 Maishitong
11.6.1 Maishitong Corporation Information
11.6.2 Maishitong Business Overview
11.6.3 Maishitong Insulin Consumables Product Models, Descriptions and Specifications
11.6.4 Maishitong Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Maishitong Recent Developments
11.7 Phray
11.7.1 Phray Corporation Information
11.7.2 Phray Business Overview
11.7.3 Phray Insulin Consumables Product Models, Descriptions and Specifications
11.7.4 Phray Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Phray Recent Developments
11.8 Apex Medical
11.8.1 Apex Medical Corporation Information
11.8.2 Apex Medical Business Overview
11.8.3 Apex Medical Insulin Consumables Product Models, Descriptions and Specifications
11.8.4 Apex Medical Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Apex Medical Recent Developments
11.9 Fornia
11.9.1 Fornia Corporation Information
11.9.2 Fornia Business Overview
11.9.3 Fornia Insulin Consumables Product Models, Descriptions and Specifications
11.9.4 Fornia Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Fornia Recent Developments
11.10 MicroTech Medical (Hangzhou) Co., Ltd
11.10.1 MicroTech Medical (Hangzhou) Co., Ltd Corporation Information
11.10.2 MicroTech Medical (Hangzhou) Co., Ltd Business Overview
11.10.3 MicroTech Medical (Hangzhou) Co., Ltd Insulin Consumables Product Models, Descriptions and Specifications
11.10.4 MicroTech Medical (Hangzhou) Co., Ltd Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 MicroTech Medical (Hangzhou) Co., Ltd Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Insulin Consumables Industry Chain
12.2 Insulin Consumables Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Insulin Consumables Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Insulin Consumables Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Insulin Consumables Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Insulin Consumables Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Insulin Consumables: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Insulin Consumables Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Patch Pump
1.2.3 Conventional Pump
1.3 Market Segmentation by Application
1.3.1 Global Insulin Consumables Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Insulin Consumables Revenue Estimates and Forecasts 2020-2031
2.2 Global Insulin Consumables Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Insulin Consumables Sales Estimates and Forecasts 2020-2031
2.4 Global Insulin Consumables Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Insulin Consumables Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Insulin Consumables Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Patch Pump Market Size by Manufacturers
3.5.2 Conventional Pump Market Size by Manufacturers
3.6 Global Insulin Consumables Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Insulin Consumables Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Insulin Consumables Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Insulin Consumables Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Insulin Consumables Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Insulin Consumables Sales and Revenue by Type (2020-2031)
6.4 North America Insulin Consumables Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Insulin Consumables Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Insulin Consumables Sales and Revenue by Type (2020-2031)
7.4 Europe Insulin Consumables Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Insulin Consumables Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Insulin Consumables Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Insulin Consumables Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Insulin Consumables Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Insulin Consumables Sales and Revenue by Type (2020-2031)
9.4 Central and South America Insulin Consumables Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Insulin Consumables Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Insulin Consumables Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Insulin Consumables Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Insulin Consumables Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Insulin Consumables Product Models, Descriptions and Specifications
11.1.4 Medtronic Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Insulin Consumables Sales by Product in 2024
11.1.6 Medtronic Insulin Consumables Sales by Application in 2024
11.1.7 Medtronic Insulin Consumables Sales by Geographic Area in 2024
11.1.8 Medtronic Insulin Consumables SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 SOOIL
11.2.1 SOOIL Corporation Information
11.2.2 SOOIL Business Overview
11.2.3 SOOIL Insulin Consumables Product Models, Descriptions and Specifications
11.2.4 SOOIL Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 SOOIL Insulin Consumables Sales by Product in 2024
11.2.6 SOOIL Insulin Consumables Sales by Application in 2024
11.2.7 SOOIL Insulin Consumables Sales by Geographic Area in 2024
11.2.8 SOOIL Insulin Consumables SWOT Analysis
11.2.9 SOOIL Recent Developments
11.3 Insulet
11.3.1 Insulet Corporation Information
11.3.2 Insulet Business Overview
11.3.3 Insulet Insulin Consumables Product Models, Descriptions and Specifications
11.3.4 Insulet Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Insulet Insulin Consumables Sales by Product in 2024
11.3.6 Insulet Insulin Consumables Sales by Application in 2024
11.3.7 Insulet Insulin Consumables Sales by Geographic Area in 2024
11.3.8 Insulet Insulin Consumables SWOT Analysis
11.3.9 Insulet Recent Developments
11.4 Tandem
11.4.1 Tandem Corporation Information
11.4.2 Tandem Business Overview
11.4.3 Tandem Insulin Consumables Product Models, Descriptions and Specifications
11.4.4 Tandem Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Tandem Insulin Consumables Sales by Product in 2024
11.4.6 Tandem Insulin Consumables Sales by Application in 2024
11.4.7 Tandem Insulin Consumables Sales by Geographic Area in 2024
11.4.8 Tandem Insulin Consumables SWOT Analysis
11.4.9 Tandem Recent Developments
11.5 LenoMed Medical
11.5.1 LenoMed Medical Corporation Information
11.5.2 LenoMed Medical Business Overview
11.5.3 LenoMed Medical Insulin Consumables Product Models, Descriptions and Specifications
11.5.4 LenoMed Medical Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 LenoMed Medical Insulin Consumables Sales by Product in 2024
11.5.6 LenoMed Medical Insulin Consumables Sales by Application in 2024
11.5.7 LenoMed Medical Insulin Consumables Sales by Geographic Area in 2024
11.5.8 LenoMed Medical Insulin Consumables SWOT Analysis
11.5.9 LenoMed Medical Recent Developments
11.6 Maishitong
11.6.1 Maishitong Corporation Information
11.6.2 Maishitong Business Overview
11.6.3 Maishitong Insulin Consumables Product Models, Descriptions and Specifications
11.6.4 Maishitong Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Maishitong Recent Developments
11.7 Phray
11.7.1 Phray Corporation Information
11.7.2 Phray Business Overview
11.7.3 Phray Insulin Consumables Product Models, Descriptions and Specifications
11.7.4 Phray Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Phray Recent Developments
11.8 Apex Medical
11.8.1 Apex Medical Corporation Information
11.8.2 Apex Medical Business Overview
11.8.3 Apex Medical Insulin Consumables Product Models, Descriptions and Specifications
11.8.4 Apex Medical Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Apex Medical Recent Developments
11.9 Fornia
11.9.1 Fornia Corporation Information
11.9.2 Fornia Business Overview
11.9.3 Fornia Insulin Consumables Product Models, Descriptions and Specifications
11.9.4 Fornia Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Fornia Recent Developments
11.10 MicroTech Medical (Hangzhou) Co., Ltd
11.10.1 MicroTech Medical (Hangzhou) Co., Ltd Corporation Information
11.10.2 MicroTech Medical (Hangzhou) Co., Ltd Business Overview
11.10.3 MicroTech Medical (Hangzhou) Co., Ltd Insulin Consumables Product Models, Descriptions and Specifications
11.10.4 MicroTech Medical (Hangzhou) Co., Ltd Insulin Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 MicroTech Medical (Hangzhou) Co., Ltd Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Insulin Consumables Industry Chain
12.2 Insulin Consumables Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Insulin Consumables Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Insulin Consumables Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Insulin Consumables Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Insulin Consumables Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Insulin Consumables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Insulin Consumables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Insulin Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Insulin Consumables Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Insulin Consumables Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Insulin Consumables Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Insulin Consumables Sales by Region (2020-2025) & (K Units)
Table 8. Global Insulin Consumables Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Insulin Consumables Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Insulin Consumables Sales Share by Manufacturers (2020-2025)
Table 12. Global Insulin Consumables Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Insulin Consumables Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Insulin Consumables by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Consumables as of 2024)
Table 16. Global Insulin Consumables Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Insulin Consumables Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Insulin Consumables Manufacturing Base and Headquarters
Table 19. Global Insulin Consumables Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Insulin Consumables Sales by Type (2020-2025) & (K Units)
Table 23. Global Insulin Consumables Sales by Type (2026-2031) & (K Units)
Table 24. Global Insulin Consumables Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Insulin Consumables Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Insulin Consumables ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Insulin Consumables Sales by Application (2020-2025) & (K Units)
Table 29. Global Insulin Consumables Sales by Application (2026-2031) & (K Units)
Table 30. Insulin Consumables High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Insulin Consumables Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Insulin Consumables Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Insulin Consumables ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Insulin Consumables Growth Accelerators and Market Barriers
Table 37. North America Insulin Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Insulin Consumables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Insulin Consumables Growth Accelerators and Market Barriers
Table 40. Europe Insulin Consumables Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Insulin Consumables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Insulin Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Insulin Consumables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Insulin Consumables Growth Accelerators and Market Barriers
Table 45. Southeast Asia Insulin Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Insulin Consumables Investment Opportunities and Key Challenges
Table 47. Central and South America Insulin Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Insulin Consumables Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Insulin Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Insulin Consumables SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. SOOIL Corporation Information
Table 60. SOOIL Description and Major Businesses
Table 61. SOOIL Product Models, Descriptions and Specifications
Table 62. SOOIL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. SOOIL Sales Value Proportion by Product in 2024
Table 64. SOOIL Sales Value Proportion by Application in 2024
Table 65. SOOIL Sales Value Proportion by Geographic Area in 2024
Table 66. SOOIL Insulin Consumables SWOT Analysis
Table 67. SOOIL Recent Developments
Table 68. Insulet Corporation Information
Table 69. Insulet Description and Major Businesses
Table 70. Insulet Product Models, Descriptions and Specifications
Table 71. Insulet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Insulet Sales Value Proportion by Product in 2024
Table 73. Insulet Sales Value Proportion by Application in 2024
Table 74. Insulet Sales Value Proportion by Geographic Area in 2024
Table 75. Insulet Insulin Consumables SWOT Analysis
Table 76. Insulet Recent Developments
Table 77. Tandem Corporation Information
Table 78. Tandem Description and Major Businesses
Table 79. Tandem Product Models, Descriptions and Specifications
Table 80. Tandem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Tandem Sales Value Proportion by Product in 2024
Table 82. Tandem Sales Value Proportion by Application in 2024
Table 83. Tandem Sales Value Proportion by Geographic Area in 2024
Table 84. Tandem Insulin Consumables SWOT Analysis
Table 85. Tandem Recent Developments
Table 86. LenoMed Medical Corporation Information
Table 87. LenoMed Medical Description and Major Businesses
Table 88. LenoMed Medical Product Models, Descriptions and Specifications
Table 89. LenoMed Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. LenoMed Medical Sales Value Proportion by Product in 2024
Table 91. LenoMed Medical Sales Value Proportion by Application in 2024
Table 92. LenoMed Medical Sales Value Proportion by Geographic Area in 2024
Table 93. LenoMed Medical Insulin Consumables SWOT Analysis
Table 94. LenoMed Medical Recent Developments
Table 95. Maishitong Corporation Information
Table 96. Maishitong Description and Major Businesses
Table 97. Maishitong Product Models, Descriptions and Specifications
Table 98. Maishitong Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Maishitong Recent Developments
Table 100. Phray Corporation Information
Table 101. Phray Description and Major Businesses
Table 102. Phray Product Models, Descriptions and Specifications
Table 103. Phray Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Phray Recent Developments
Table 105. Apex Medical Corporation Information
Table 106. Apex Medical Description and Major Businesses
Table 107. Apex Medical Product Models, Descriptions and Specifications
Table 108. Apex Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Apex Medical Recent Developments
Table 110. Fornia Corporation Information
Table 111. Fornia Description and Major Businesses
Table 112. Fornia Product Models, Descriptions and Specifications
Table 113. Fornia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Fornia Recent Developments
Table 115. MicroTech Medical (Hangzhou) Co., Ltd Corporation Information
Table 116. MicroTech Medical (Hangzhou) Co., Ltd Description and Major Businesses
Table 117. MicroTech Medical (Hangzhou) Co., Ltd Product Models, Descriptions and Specifications
Table 118. MicroTech Medical (Hangzhou) Co., Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. MicroTech Medical (Hangzhou) Co., Ltd Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Consumables Product Picture
Figure 2. Global Insulin Consumables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Patch Pump Product Picture
Figure 4. Conventional Pump Product Picture
Figure 5. Global Insulin Consumables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Type I Diabetes
Figure 7. Type II Diabetes
Figure 8. Insulin Consumables Report Years Considered
Figure 9. Global Insulin Consumables Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 11. Global Insulin Consumables Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Insulin Consumables Revenue Market Share by Region (2020-2031)
Figure 13. Global Insulin Consumables Sales (2020-2031) & (K Units)
Figure 14. Global Insulin Consumables Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Insulin Consumables Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Insulin Consumables Sales Volume Market Share in 2024
Figure 17. Global Insulin Consumables Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Patch Pump Revenue Market Share by Manufacturer in 2024
Figure 20. Conventional Pump Revenue Market Share by Manufacturer in 2024
Figure 21. Global Insulin Consumables Sales Market Share by Type (2020-2031)
Figure 22. Global Insulin Consumables Revenue Market Share by Type (2020-2031)
Figure 23. Global Insulin Consumables Sales Market Share by Application (2020-2031)
Figure 24. Global Insulin Consumables Revenue Market Share by Application (2020-2031)
Figure 25. North America Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 26. North America Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 28. North America Insulin Consumables Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Insulin Consumables Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 38. Europe Insulin Consumables Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Insulin Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 43. France Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Insulin Consumables Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Insulin Consumables Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 58. India Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Insulin Consumables Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Insulin Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Insulin Consumables Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Insulin Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 79. Insulin Consumables Industry Chain Mapping
Figure 80. Regional Insulin Consumables Manufacturing Base Distribution (%)
Figure 81. Global Insulin Consumables Production Market Share by Region (2020-2031)
Figure 82. Insulin Consumables Production Process
Figure 83. Regional Insulin Consumables Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Table 1. Global Insulin Consumables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Insulin Consumables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Insulin Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Insulin Consumables Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Insulin Consumables Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Insulin Consumables Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Insulin Consumables Sales by Region (2020-2025) & (K Units)
Table 8. Global Insulin Consumables Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Insulin Consumables Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Insulin Consumables Sales Share by Manufacturers (2020-2025)
Table 12. Global Insulin Consumables Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Insulin Consumables Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Insulin Consumables by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Consumables as of 2024)
Table 16. Global Insulin Consumables Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Insulin Consumables Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Insulin Consumables Manufacturing Base and Headquarters
Table 19. Global Insulin Consumables Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Insulin Consumables Sales by Type (2020-2025) & (K Units)
Table 23. Global Insulin Consumables Sales by Type (2026-2031) & (K Units)
Table 24. Global Insulin Consumables Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Insulin Consumables Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Insulin Consumables ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Insulin Consumables Sales by Application (2020-2025) & (K Units)
Table 29. Global Insulin Consumables Sales by Application (2026-2031) & (K Units)
Table 30. Insulin Consumables High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Insulin Consumables Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Insulin Consumables Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Insulin Consumables ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Insulin Consumables Growth Accelerators and Market Barriers
Table 37. North America Insulin Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Insulin Consumables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Insulin Consumables Growth Accelerators and Market Barriers
Table 40. Europe Insulin Consumables Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Insulin Consumables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Insulin Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Insulin Consumables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Insulin Consumables Growth Accelerators and Market Barriers
Table 45. Southeast Asia Insulin Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Insulin Consumables Investment Opportunities and Key Challenges
Table 47. Central and South America Insulin Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Insulin Consumables Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Insulin Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Insulin Consumables SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. SOOIL Corporation Information
Table 60. SOOIL Description and Major Businesses
Table 61. SOOIL Product Models, Descriptions and Specifications
Table 62. SOOIL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. SOOIL Sales Value Proportion by Product in 2024
Table 64. SOOIL Sales Value Proportion by Application in 2024
Table 65. SOOIL Sales Value Proportion by Geographic Area in 2024
Table 66. SOOIL Insulin Consumables SWOT Analysis
Table 67. SOOIL Recent Developments
Table 68. Insulet Corporation Information
Table 69. Insulet Description and Major Businesses
Table 70. Insulet Product Models, Descriptions and Specifications
Table 71. Insulet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Insulet Sales Value Proportion by Product in 2024
Table 73. Insulet Sales Value Proportion by Application in 2024
Table 74. Insulet Sales Value Proportion by Geographic Area in 2024
Table 75. Insulet Insulin Consumables SWOT Analysis
Table 76. Insulet Recent Developments
Table 77. Tandem Corporation Information
Table 78. Tandem Description and Major Businesses
Table 79. Tandem Product Models, Descriptions and Specifications
Table 80. Tandem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Tandem Sales Value Proportion by Product in 2024
Table 82. Tandem Sales Value Proportion by Application in 2024
Table 83. Tandem Sales Value Proportion by Geographic Area in 2024
Table 84. Tandem Insulin Consumables SWOT Analysis
Table 85. Tandem Recent Developments
Table 86. LenoMed Medical Corporation Information
Table 87. LenoMed Medical Description and Major Businesses
Table 88. LenoMed Medical Product Models, Descriptions and Specifications
Table 89. LenoMed Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. LenoMed Medical Sales Value Proportion by Product in 2024
Table 91. LenoMed Medical Sales Value Proportion by Application in 2024
Table 92. LenoMed Medical Sales Value Proportion by Geographic Area in 2024
Table 93. LenoMed Medical Insulin Consumables SWOT Analysis
Table 94. LenoMed Medical Recent Developments
Table 95. Maishitong Corporation Information
Table 96. Maishitong Description and Major Businesses
Table 97. Maishitong Product Models, Descriptions and Specifications
Table 98. Maishitong Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Maishitong Recent Developments
Table 100. Phray Corporation Information
Table 101. Phray Description and Major Businesses
Table 102. Phray Product Models, Descriptions and Specifications
Table 103. Phray Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Phray Recent Developments
Table 105. Apex Medical Corporation Information
Table 106. Apex Medical Description and Major Businesses
Table 107. Apex Medical Product Models, Descriptions and Specifications
Table 108. Apex Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Apex Medical Recent Developments
Table 110. Fornia Corporation Information
Table 111. Fornia Description and Major Businesses
Table 112. Fornia Product Models, Descriptions and Specifications
Table 113. Fornia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Fornia Recent Developments
Table 115. MicroTech Medical (Hangzhou) Co., Ltd Corporation Information
Table 116. MicroTech Medical (Hangzhou) Co., Ltd Description and Major Businesses
Table 117. MicroTech Medical (Hangzhou) Co., Ltd Product Models, Descriptions and Specifications
Table 118. MicroTech Medical (Hangzhou) Co., Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. MicroTech Medical (Hangzhou) Co., Ltd Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Consumables Product Picture
Figure 2. Global Insulin Consumables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Patch Pump Product Picture
Figure 4. Conventional Pump Product Picture
Figure 5. Global Insulin Consumables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Type I Diabetes
Figure 7. Type II Diabetes
Figure 8. Insulin Consumables Report Years Considered
Figure 9. Global Insulin Consumables Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 11. Global Insulin Consumables Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Insulin Consumables Revenue Market Share by Region (2020-2031)
Figure 13. Global Insulin Consumables Sales (2020-2031) & (K Units)
Figure 14. Global Insulin Consumables Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Insulin Consumables Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Insulin Consumables Sales Volume Market Share in 2024
Figure 17. Global Insulin Consumables Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Patch Pump Revenue Market Share by Manufacturer in 2024
Figure 20. Conventional Pump Revenue Market Share by Manufacturer in 2024
Figure 21. Global Insulin Consumables Sales Market Share by Type (2020-2031)
Figure 22. Global Insulin Consumables Revenue Market Share by Type (2020-2031)
Figure 23. Global Insulin Consumables Sales Market Share by Application (2020-2031)
Figure 24. Global Insulin Consumables Revenue Market Share by Application (2020-2031)
Figure 25. North America Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 26. North America Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 28. North America Insulin Consumables Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Insulin Consumables Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 38. Europe Insulin Consumables Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Insulin Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 43. France Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Insulin Consumables Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Insulin Consumables Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 58. India Insulin Consumables Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Insulin Consumables Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Insulin Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Insulin Consumables Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Insulin Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Insulin Consumables Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Insulin Consumables Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Insulin Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Insulin Consumables Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Insulin Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Insulin Consumables Revenue (2020-2025) & (US$ Million)
Figure 79. Insulin Consumables Industry Chain Mapping
Figure 80. Regional Insulin Consumables Manufacturing Base Distribution (%)
Figure 81. Global Insulin Consumables Production Market Share by Region (2020-2031)
Figure 82. Insulin Consumables Production Process
Figure 83. Regional Insulin Consumables Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232